Clinical trials recruiting for Cadonilimab
4
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 3Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cadonilimab | 2 |
| Bevacizumab | 1 |
| Cadonilimab + bevacizumab + FOLFOX | 1 |
| Nanoliposomal Irinotecan+Oxaliplatin +Capecitabine+Cadonilimab | 1 |
Self-screener
Recruiting trials
- Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer
- Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer
- Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
- NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC
Related conditions
Trials recruiting for Cadonilimab often also study these conditions. Each links to its own recruiting-trial list.
Triple-negative breast cancer 138RAS Mutation 6Pancreatic cancer 870Pancreatic Adenocarcinoma 49Microsatellite Stable Colorectal Carcinoma 3Metastatic Colorectal Cancer 60Lung cancer 2180Hepatocellular carcinoma 51Drug Use 9Colorectal cancer 1359
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Cadonilimab trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.